Laurus Labs surges 6% to hit over 4-month high

Analysts remain optimistic on the company's outlook for FY23 & FY24 with new capacity addition for commercial usage for FDF and API segments, ARV business and robust growth expected in CS business.

Shares of Laurus Labs hit an over four-month high of Rs 587.65, surging 6 per cent on the BSE in Friday’s intra-day trade on heavy volumes. The stock of the pharmaceutical company was trading at the highest level since October 21, 2021. It had hit a record high of Rs 724 on August 12, 2021.

At 12:02 pm; Laurus Labs was up 4 per cent at Rs 577, as compared to a 0.20 per cent rise in the S&P BSE Sensex. The trading volumes on the counter jumped 1.3 times with a combined 2.9 million equity shares having changed